13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q3 2024. See the latest, Q2 2026 →
Reported value
$570.97B
+1.9% on the quarter before
Positions
1,910
201 new · 165 sold out
Top 10
23.4%
of the value
Est. gain
+$32.66B
on stocks held all quarter
Est. return
+6.5%
on those stocks since Q2 2024
Positions as of Sep 30, 2024, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 35% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2024. Striped tiles are options.
Largest buys
Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nasdaq Inc~$1.76BAdded · 0.2% → 0.5%+24,084,154 shares
- Wells Fargo Co New~$1.10BAdded · 0.8% → 0.9%+19,412,927 shares
- Gilead Sciences Inc~$978.0MAdded · 0.3% → 0.5%+11,665,593 shares
- Edwards Lifesciences Corp~$964.1MAdded · 0.3% → 0.4%+14,610,123 shares
- Nvidia~$906.6MAdded · 3.1% → 3.1%+7,465,586 shares
- Oreilly Automotive Inc~$838.4MAdded · 0.2% → 0.3%+728,040 shares
- Eversource Energy~$808.8MNew · 0.0% → 0.1%+11,885,124 shares
- Eqt Corp~$758.5MAdded · 0.4% → 0.5%+20,700,921 shares
- Deere & Co~$744.1MAdded · 0.4% → 0.5%+1,782,984 shares
- Starbucks Corp~$740.7MAdded · 0.1% → 0.3%+7,598,146 shares
Largest sells
Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Eog Res Inc~$1.82BCut · 0.4% → 0.1%−14,821,048 shares
- Apple~$1.75BCut · 3.9% → 3.9%−7,523,962 shares
- Hca Healthcare Inc~$1.51BCut · 0.6% → 0.5%−3,726,592 shares
- SPDR S&P 500 ETF Tr~$1.48BCut · 0.3% → 0.0%−2,571,127 shares
- Pnc Finl Svcs Group Inc~$1.29BCut · 0.3% → 0.1%−6,972,137 shares
- Jpmorgan Chase & Co.~$1.29BCut · 1.3% → 1.1%−6,100,341 shares
- Rtx Corporation~$1.25BCut · 0.2% → 0.1%−10,335,541 shares
- Phillips 66~$1.13BCut · 0.3% → 0.1%−8,619,165 shares
- Zoetis Inc~$1.08BCut · 0.3% → 0.1%−5,541,594 shares
- Procter And Gamble Co~$1.03BCut · 1.0% → 0.8%−5,920,690 shares
Holdings
As of Sep 30, 2024. Changes are in shares against Jun 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +0.06% · price −3.7% | 4.1% | $23.26B | −$899.3M | ||||||||
| AppleCOM · shares −7.2% · price +10.6% | 3.9% | $22.46B | +$2.16B | ||||||||
| NvidiaCOM · shares +5.4% · price −1.7% | 3.1% | $17.79B | −$291.9M | ||||||||
| Unitedhealth Group IncCOM · shares −3.9% · price +14.8% | 2.5% | $14.54B | +$1.88B | ||||||||
| AmazonCOM · shares −1.0% · price −3.6% | 2.3% | $13.11B | −$487.0M | ||||||||
| AlphabetCAP STK CL A · shares −0.1% · price −8.9% | 1.7% | $9.45B | −$929.2M | ||||||||
| Eli LillyCOM · shares −1.5% · price −2.1% | 1.6% | $9.40B | −$206.3M | ||||||||
| Merck & Co IncCOM · shares +4.6% · price −8.3% | 1.5% | $8.61B | −$742.2M | ||||||||
| BroadcomCOM · shares +1.2% · price +39.7% | 1.5% | $8.57B | +$2.40B | ||||||||
| Danaher CorporationCOM · shares −4.8% · price +11.3% | 1.1% | $6.48B | +$656.5M | ||||||||
| Jpmorgan Chase & Co.COM · shares −17% · price +4.3% | 1.1% | $6.28B | +$256.3M | ||||||||
| MetaCL A · shares −6.7% · price +13.5% | 1.1% | $6.15B | +$732.7M | ||||||||
| Wells Fargo Co NewCOM · shares +27% · price −4.9% | 0.90% | $5.15B | −$208.3M | ||||||||
| Pfizer IncCOM · shares −1.6% · price +3.4% | 0.83% | $4.74B | +$157.2M | ||||||||
| Procter And Gamble CoCOM · shares −18% · price +5.0% | 0.82% | $4.69B | +$224.1M | ||||||||
| Mcdonalds CorpCOM · shares +0.9% · price +19.5% | 0.80% | $4.59B | +$742.8M | ||||||||
| S&P Global IncCOM · shares +3.4% · price +15.8% | 0.80% | $4.58B | +$605.6M | ||||||||
| Texas InstrumentsCOM · shares −11% · price +6.2% | 0.80% | $4.55B | +$265.5M | ||||||||
| Tjx Cos Inc NewCOM · shares −15% · price +6.8% | 0.78% | $4.43B | +$280.5M | ||||||||
| MastercardCL A · shares −4.4% · price +11.9% | 0.77% | $4.42B | +$470.8M | ||||||||
| American Express CoCOM · shares −16% · price +17.1% | 0.76% | $4.36B | +$637.3M | ||||||||
| General Dynamics CorpCOM · shares +0.8% · price +4.2% | 0.75% | $4.29B | +$170.0M | ||||||||
| Visa Inc.COM CL A · shares −18% · price +4.8% | 0.69% | $3.93B | +$178.5M | ||||||||
| Johnson & JohnsonCOM · shares −3.7% · price +10.9% | 0.68% | $3.88B | +$380.4M | ||||||||
| AlphabetCAP STK CL C · shares −4.1% · price −8.8% | 0.67% | $3.85B | −$374.0M | ||||||||
| Total · 1,910 positions | 100% | $570.97B | +$32.66B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2024 to Q3 2024: 1,608 stocks held throughout, up $32.66B (+6.5%).
- Broadcom13:1 split+$2.40B+40%
- Apple+$2.16B+11%
- Unitedhealth Group Inc+$1.88B+15%
- Mcdonalds Corp+$742.8M+19%
- Meta+$732.7M+14%
- Edwards Lifesciences Corp−$446.4M−29%
- Amazon−$487.0M−4%
- Merck & Co Inc−$742.2M−8%
- Microsoft−$899.3M−4%
- Alphabet−$929.2M−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 7 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |